Mogelijk gemaakt door Google TranslateTranslate
Latest Press Releases
View all
TimeHeadline
Just nowSummer Road Announces Shareholders Have Overwhelmingly Elected Rory A. Held to Ingles Markets’ Board of Directors
Just nowPagSeguro Files its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
Just now$4+ Billion OTC Dry Eye Drops Market Analysis Report 2026: Pfizer, Johnson & Johnson Services, and Novartis International Dominate
1m agoSemitech Named Authorized Distributor for NVE Corporation Isolator Products
1m agoUNITE HERE Urges Other PENN Entertainment Shareholders to Support Proposal to Declassify the Board
Cabaletta Bio Inc logo

Cabaletta Bio Inc

About

Cabaletta Bio Inc (NASDAQ:CABA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 28 2026
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel
Apr 28 2026
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
Apr 27 2026
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
Apr 14 2026
First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform
Mar 23 2026
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Financials

Revenue
$0
Market Cap
$335.08 M
EPS
-2.10

Community Chat

Ask AI

6ix6ix
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren